Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature review.

导出 OA

翻译打印收藏纠错

作者： Xinyi,Li ^[1] ; Xun,Wang ^[2] ; Shaodong,Wang ^[2] ; Yanguo,Liu ^[2] ; Ruilin,Wang ^[1] ; Yi,Liu ^[3] ; Lin,Huang ^[3] ; Yufei,Feng ^[3] ; Xiaohui,Xie ^[1] ; Luwen,Shi ^[1]

作者单位： Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, P.R. China. ^[1] Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, P.R. China. ^[2] Department of Pharmacy, Peking University People's Hospital, Beijing 100044, P.R. China. ^[3]

关键词 NSCLC irAEs neoadjuvant therapy thyroid dysfunction tumor progression

DOI 10.3892/ol.2023.14083

PMID 37854868

发布时间 2023-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交